By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mast Therapeutics 

12390 El Camino Real, Suite 150

San Diego  California  92130  U.S.A.
Phone: 858-552-0866 Fax: 858-552-0876


Company News
Mast Therapeutics (MSTX) Announces Amendment To Loan And Security Agreement With Hercules Technology Growth Capital 9/30/2015 6:38:47 AM
Mast Therapeutics (MSTX) Announces Presentation Of Results Of Nonclinical Study Of Vepoloxamer In Chronic Heart Failure At The HFSA's Annual Scientific Meeting 9/28/2015 11:42:58 AM
Mast Therapeutics (MSTX) To Host Analyst & Investor Day On October 7, 2015 9/24/2015 11:00:12 AM
Mast Therapeutics (MSTX) To Host Second Quarter 2015 Financial Results And Corporate Update Conference Call 8/6/2015 11:15:28 AM
Mast Therapeutics (MSTX) Announces Change In Board Of Directors 5/29/2015 7:28:50 AM
Mast Therapeutics (MSTX) Announces Initiation Of EPIC-E Study 5/26/2015 6:22:12 AM
Mast Therapeutics (MSTX) Reports First Quarter 2015 Financial Results 5/11/2015 7:04:15 AM
Enrollment In Mast Therapeutics (MSTX)' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 4/21/2015 12:03:45 PM
Mast Therapeutics (MSTX) To Present New Data Supporting Vepoloxamer (MST-188) In Sickle Cell Disease At 9th Annual Sickle Cell Disease Research And Education Symposium And 38th National Sickle Cell Disease Scientific Meeting 4/9/2015 8:05:00 AM
Mast Therapeutics (MSTX) Reports Fourth Quarter And Full Year 2014 Financial Results 3/24/2015 10:57:27 AM